Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Dr Arjun Gupta summarises his talk on 'the time toxicity of cancer care' which was presented at the "Choosing Wisely Nigeria 2023” congress on the 30th of March 2023.
He highlights the burdens of how time toxicity impacts cancer care for patients and concludes by explaining the importance of having Choosing Wisely events.
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 4th - 10th, 2023
The time toxicity of cancer care
The current status of multiple myeloma diagnosis and treatment
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours